ACTEMRA Financial Support
The ACTEMRA Copay Card Program
Genentech Rheumatology Access Solutions offers the ACTEMRA Copay Card Program to help you with the out-of-pocket costs of your ACTEMRA prescription.
How does it work?
Each eligible patient who enrolls in the Program can receive an ACTEMRA Copay Card Program MasterCard® in one of the following ways:
- Through your healthcare provider
- By calling (888) MY-ACTEMRA (888-692-2836)
- Online at ACTEMRAcard.com
Once you receive the Copay Card, you can activate it by going online at ACTEMRAcard.com or by calling (888) MY-ACTEMRA (888-692-2836).
MasterCard is a registered trademark of MasterCard International Incorporated.
When you activate your ACTEMRA Copay Card, you can use it to cover up to $4000 per 12-month period of your out-of-pocket costs for ACTEMRA
Who is eligible for the program?
New or current ACTEMRA paitents can use the Program if they:- Are using ACTEMRA to treat their systemic juvenile idiopathic arthritis (SJIA)
- For SJIA patients, a parent or caregiver who is 18 years of age or older must manage the card
- Do not have federal, state or local government-funded health insurance plans (for example, Medicare, Medicare Advantage, Medicaid or TRICARE)
- Government employees and their dependents are eligible provided the local, state or federal government does not pay for their insurance. If you have any questions, call (888) MY-ACTEMRA (888-692-2836)
- Do not live or get ACTEMRA treatments in Massachusetts
- Do not get help from the Genentech® Access to Care Foundation
The ACTEMRA Copay Card Program is not a benefit plan. The Program helps with co-pays for ACTEMRA only. It does not pay for other costs related to your or your child's visit or infusion.
Genentech reserves the right to change or end this program. This may be done in whole or in part, without notice, at any time.
For full program terms, call (888) MY-ACTEMRA
This information does not take the place of talking to your child's healthcare provider about either your child's medical condition or your child's treatment with ACTEMRA. Talk with your child's healthcare provider if you have any questions about your child's treatment with ACTEMRA.
What is ACTEMRA?
ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat patients with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older.
IMPORTANT SIDE EFFECT INFORMATION
Some people have serious infections while taking ACTEMRA, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.
Other serious side effects of ACTEMRA include tears (perforation) of the stomach and intestines, changes in blood test results, (including low neutrophil count, low platelet count, increase in certain liver function tests, and increase in blood cholesterol levels), hepatitis B infection becoming an active infection again, and nervous system problems.
ACTEMRA affects the immune system and may increase your risk of certain cancers.
Serious allergic reactions, including death, can happen with ACTEMRA. These reactions may happen with any infusion of ACTEMRA, even if they did not occur with an earlier infusion. Patients must tell their doctor if they have had a previous reaction to ACTEMRA. Patients should not take ACTEMRA if they are allergic to it or any of its ingredients.
Common side effects with ACTEMRA in patients with SJIA include upper respiratory tract infections (common cold, sinus infections), headache, and diarrhea.
Patients must tell their healthcare provider if they plan to become pregnant or are pregnant. It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while taking ACTEMRA must contact the registry at 1-877-311-8972 and talk to their healthcare provider.
Patients must call their healthcare provider for medical advice about any side effects. Patients or caregivers may report side effects to the FDA at 1-800-FDA-1088. Patients or caregivers may also report side effects to Genentech at 1-888-835-2555.
For additional important safety information, including Boxed Warning and Medication Guide, please visit ACTEMRA.com or call (800) ACTEMRA (800-228-3672).
The resource above is provided in Adobe® Reader® format (PDF). To view or print, you must have Adobe Reader (version 3.0 or higher) installed on your computer. Download the free Adobe Reader here.
